Evidence map›Paper›PMID 41645183›Full record

ArticleJournal of neuroinflammation2026

Cell-intrinsic vulnerability and immune activation cooperate to drive degeneration in a mitochondrial complex I deficiency model of optic neuropathy.

Daniela Santamaría-Muñoz, Raenier V Reyes, Miranda R Krueger, Andrea García-Llorca, Brennan Marsh-Armstrong, Xin Duan, Yang Hu, Derek S Welsbie, Nicholas Marsh-Armstrong, Elisenda Sanz and 3 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Daniela Santamaría-MuñozDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA.
Raenier V ReyesDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA.
Miranda R KruegerDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA.
Andrea García-LlorcaDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA.
Brennan Marsh-ArmstrongDepartment of Anesthesiology, Maine Health, Maine Medical Center, Portland, ME, USA.
Xin DuanDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
Yang HuDepartment of Ophthalmology, Stanford University, Palo Alto, CA, USA.
Derek S WelsbieDepartment of Ophthalmology, University of California San Diego, San Diego, CA, USA.
Nicholas Marsh-ArmstrongDepartment of Ophthalmology and Vision Science, University of California Davis, Davis, CA, USA.
Elisenda SanzDepartment of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona. Bellaterra, Barcelona, Spain.
Albert QuintanaDepartment of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona. Bellaterra, Barcelona, Spain.
Sergi SimóDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA.
Anna La TorreDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, CA, USA. alatorre@health.ucdavis.edu.

Funding

Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve RegenerationR01EY024932 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI Yang Hu · 2015 to 2026
$4.8M
Mechanisms Underlying Type II Cadherin Guided Assembly of Retinal CircuitsR01EY030138 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Xin Duan · 2020 to 2026
$3.2M
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanismR01EY032518 · NEI · STANFORD UNIVERSITY · PI Yang Hu · 2022 to 2026
$2.7M
Developing ER Stress Chemical Modulators as Neuroprotectants for GlaucomaR01EY036943 · NEI · STANFORD UNIVERSITY · PI Yang Hu · 2025 to 2026
$1.0M
Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR-323Glaucoma Research Foundation Catalyst for a Cure'la Caixa' Foundation 100010434Ministerio de Ciencia e Innovación PID2020-114977RB-I00Ministerio de Ciencia e Innovación RTI2018-101838-J-I00NEI NIH HHS 1R21EY037445NEI NIH HHS EY012576NEI NIH HHS NIHR01EY030138NEI NIH HHS R01 EY024932NEI NIH HHS R01 EY030138NEI NIH HHS R01 EY032518NEI NIH HHS R01 EY036943University of California, Davis Team Science Award
6 · The paper itself

Abstract

Mitochondrial dysfunction is a central hallmark of many optic neuropathies, yet the mechanisms linking intrinsic metabolic stress to retinal ganglion cell (RGC) degeneration remain unclear. To bridge this gap, we developed conditional transgenic models targeting the mitochondrial complex I subunit Ndufs4 in the retina. Broad deletion of Ndufs4 in the retina resulted in vision loss, progressive RGC degeneration, and pronounced immune activation before overt RGC death. Strikingly, depletion of myeloid cells significantly preserved RGCs, demonstrating that inflammation is not simply a downstream consequence but a participant in the degeneration process. To further distinguish between intrinsic and extrinsic mechanisms, we generated a mosaic model in which only subsets of retinal cells lacked Ndufs4. In this paradigm, the degeneration first appeared selectively in mutant regions, suggesting that mitochondrial impairment within RGCs is necessary to initiate vulnerability. At later stages, however, the degeneration extended beyond mutant territories, highly suggestive of a propagation through non-cell autonomous processes. Together, these findings support a model in which mitochondrial dysfunction creates the conditions for neuronal vulnerability, while immune responses govern the timing and extent of cell loss. This framework explains the consistent co-occurrence of metabolic deficits and neuroinflammation in optic neuropathies and highlights the importance of their interactions in disease progression. By clarifying the intersection of intrinsic and extrinsic mechanisms, this work advances our understanding of RGC degeneration and provides a conceptual basis for deciphering pathogenic processes across diverse optic neuropathies.

Indexed as

Electron Transport Complex IMitochondrial DiseasesOptic Nerve DiseasesRetinal Ganglion CellsAnimalsDisease Models, AnimalMiceMice, TransgenicMitochondriaElectron Transport Complex INdufs4 protein, mouse

Identifiers

PMID41645183
PMCPMC12977552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.